Current State of M&A in the Pharmaceutical Industry: Implications, Opportunities and Threats
09 June, 2016 - Thursday
Dolce Basking Ridge300 N Maple Ave, Basking Ridge, NJ 07920

Over the last few years, Pharmaceutical industry has seen record number of mergers and acquisitions (M&A) deals.  Transactions between large and small companies, across the value chain, and across geographies have taken place.  On June 9th, 2016, Nailesh A. Bhatt, Founder and Managing Director of Proximare – a strategic advisory firm will present a comprehensive perspective on the “Current State of M&A in the Pharmaceutical Industry: Implications, Opportunities and Threats”.  In his unique presentation, Mr. Bhatt will cover the following key topics that are relevant, timely and thought provoking:

 

  • Current State of the Industry
  • Type of Deals
  • Rationale for Deals
  • Implications, opportunities and threats as a direct result of the continued consolidation
  • Looking ahead at the Future

The presentation will be followed with ample time for questions and answers and networking.

Agenda

Registration begins at 5:30PM

Cocktail Hour: 6-7PM

Welcome Address and Presentation: 7-8Pm

Dinner: 8-9PM

Meeting Materials

Speaker(s)

Mr. Nailesh Bhatt

Mr. Nailesh Bhatt

Designation: Managing Director at Proximare, Inc

Nailesh A. Bhatt is the founder and Managing Director of Proximare – a strategic advisory firm that develops and implements growth strategies with an exclusive focus on Pharmaceutical, Life Sciences and Healthcare industries. With presence in Princeton, London and Mumbai, Proximare serves a wide range of clients, including: large pharma, generics, PE groups, CROs, CMOs, wholesalers, distributors, PBMs, Payers, retailers, GPOs, and more.

 

Prior to founding Proximare in 2001, Nailesh was the founder of BulkDrugs.com, a business-to-business e-commerce company. Before BulkDrugs.com, Nailesh worked in a wide range of increasing roles and responsibilities at: Seppic and Arthur Andersen.

 

Nailesh is a recognized and sought after expert on a wide range of issues including: strategy, generics, biosimilars, specialty drugs, licensing, M&A, India and China.

 

In 2015, Nailesh founded an investment fund that invests in life sciences and healthcare companies.

 

Nailesh is heavily involved in cross-border M&A, licensing, and partnering deals and brings a unique perspective to our discussion today.

 

Contact information:

Nailesh A. Bhatt, Managing Director

Proximare Inc.

100 Overlook Center, 2nd Floor. Princeton, NJ 08540

Website:  www.proximare.com